Delivery Order SPE2DB20D3505-SPE2DB24FU6S8

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D1106|SPE2DB24FEYJ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $10,495.86 and an ultimate completion date of June 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM62F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a firm fixed price of $15,235.82 and a completion date of May 15, 2024. The contract is a delivery order, and is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $15,549.46, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 24, 2025. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. Amerisourcebergen, a major...
This federal contract award, identified as SPE2DB22D1017|SPE2DB25FF2UD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,180.51 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,562.31, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of April 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award, valued at $44,749.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,287.85, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 28, 2023 and is a Firm Fixed Price agreement. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of 4560957345 units of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA). The fixed-price delivery order, with a ceiling value of $29,265.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 17, 2023 and was awarded on May 16, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,261.67, is for the delivery of OTEZLA 30 MG TABLET 60S to support federal healthcare programs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,268.49, is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU6S8
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3505|SPE2DB24FU6S8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565232521 units of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,510.33 and a completion date of July 24, 2024.

The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:54 AM